Ultrasound enhancing agents in cardiovascular imaging: expanding horizons beyond coronary arteries.

Cardiovascular diagnostics Microvascular obstruction (MVO) Peripheral artery disease (PAD) Sonothrombolysis Ultrasound enhancing agents (UEAs)

Journal

Cardiovascular ultrasound
ISSN: 1476-7120
Titre abrégé: Cardiovasc Ultrasound
Pays: England
ID NLM: 101159952

Informations de publication

Date de publication:
08 Aug 2024
Historique:
received: 21 05 2024
accepted: 31 07 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 8 8 2024
Statut: epublish

Résumé

From its inception as a two-dimensional snapshot of the beating heart, echocardiography has become an indelible part of cardiovascular diagnostics. The integration of ultrasound enhancing agents (UEAs) marks a pivotal transition, enhancing its diagnostic acumen beyond myocardial perfusion. These agents have refined echocardiography's capacity to visualize complex cardiac anatomy and pathology with unprecedented clarity, especially in non-coronary artery disease contexts. UEAs aid in detailed assessments of myocardial viability, endocardial border delineation in left ventricular opacification, and identification of intracardiac masses. Recent innovations in UEAs, accompanied by advancements in echocardiographic technology, offer clinicians a more nuanced view of cardiac function and blood flow dynamics. This review explores recent developments in these applications and future contemplated studies.

Identifiants

pubmed: 39118073
doi: 10.1186/s12947-024-00330-2
pii: 10.1186/s12947-024-00330-2
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Informations de copyright

© 2024. The Author(s).

Références

Maleki M, Esmaeilzadeh M. The evolutionary development of echocardiography. Iran J Med Sci. 2012;37(4):222–32.
pubmed: 23390327 pmcid: 3565194
Fraiche AM, Strom JB. Impact of ultrasound enhancing agents on clinical management. Curr Opin Cardiol. 2022;37(5):389–93.
doi: 10.1097/HCO.0000000000000973 pubmed: 35913366 pmcid: 9378600
Cotter B, Raisinghani A, DeMaria AN. Established and emerging roles for ultrasound enhancing agents (contrast echocardiography). Clin Cardiol. 2022;45(11):1114–22.
doi: 10.1002/clc.23924 pubmed: 36183366 pmcid: 9707559
Dave JK, Mc Donald ME, Mehrotra P, Kohut AR, Eisenbrey JR, Forsberg F. Recent technological advancements in cardiac ultrasound imaging. Ultrasonics. 2018;84:329–40.
doi: 10.1016/j.ultras.2017.11.013 pubmed: 29223692
Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography [published correction appears in Eur Heart J Cardiovasc Imaging. 2017 May 1;18(8):832]. Eur Heart J Cardiovasc Imaging. 2016;17(11):1191–229.
doi: 10.1093/ehjci/jew190 pubmed: 27880640
Najjar R. Redefining radiology: a review of artificial intelligence integration in medical imaging. Diagnostics (Basel). 2023;13(17):2760.
doi: 10.3390/diagnostics13172760 pubmed: 37685300
Salih S, Elliyanti A, Alkatheeri A, AlYafei F, Almarri B, Khan H. The role of molecular imaging in personalized medicine. J Pers Med. 2023;13(2):369.
doi: 10.3390/jpm13020369 pubmed: 36836603 pmcid: 9959741
Mason ON, Davidson BP, Sheeran P, Muller M, Hodovan JM, Sutton J, Powers J, Lindner JR. Augmentation of tissue perfusion in patients with peripheral artery disease using microbubble cavitation. Cardiovasc Imaging. 2020;13(3):641–51.
Muller MA, et al. Treatment of limb ischemia with conducted effects of catheter-based endovascular ultrasound. Ultrasound Med Biol. 2021;47(8):2277–85.
doi: 10.1016/j.ultrasmedbio.2021.03.019 pubmed: 33934942 pmcid: 8243793
Mathias W Jr, Tsutsui JM, Tavares BG, et al. Sonothrombolysis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2019;73(22):2832–42.
doi: 10.1016/j.jacc.2019.03.006 pubmed: 30894317
Bainey KR, Abulhamayel A, Aziz A, Becher H. Sonothrombolysis augments reperfusion in ST-elevation myocardial infarction with primary percutaneous coronary intervention: insights from the SONOSTEMI study. CJC Open. 2022;4(7):644–6.
doi: 10.1016/j.cjco.2022.03.004 pubmed: 35865027 pmcid: 9294977
de Jong N, Emmer M, van Wamel A, Versluis M. Ultrasonic characterization of ultrasound contrast agents. Med Biol Eng Comput. 2009;47(8):861–73.
doi: 10.1007/s11517-009-0497-1 pubmed: 19468770 pmcid: 2727586
Şen T, Tüfekçioğlu O, Koza Y. Mechanical index. Anatol J Cardiol. 2015;15(4):334–6.
doi: 10.5152/akd.2015.6061 pubmed: 25880292 pmcid: 5336845
Guan L, Wang C, Yan X, Liu L, Li Y, Mu Y. A thrombolytic therapy using diagnostic ultrasound combined with RGDS-targeted microbubbles and urokinase in a rabbit model [published correction appears in Sci Rep. 2020 Sep 22;10(1):15767]. Sci Rep. 2020;10(1):12511.
doi: 10.1038/s41598-020-69202-9 pubmed: 32719362 pmcid: 7385658
Bader KB, Bouchoux G, Holland CK. Sonothrombolysis. Adv Exp Med Biol. 2016;880:339–62.
doi: 10.1007/978-3-319-22536-4_19 pubmed: 26486347 pmcid: 4933511
Bader KB, Gruber MJ, Holland CK. Shaken and stirred: mechanisms of ultrasound-enhanced thrombolysis. Ultrasound Med Biol. 2015;41(1):187–96.
doi: 10.1016/j.ultrasmedbio.2014.08.018 pubmed: 25438846
Kaul S, et al. A suggested roadmap for cardiovascular ultrasound research for the future. Jo Am Soc Echocardiogr. 2011;24(4):455–64.
doi: 10.1016/j.echo.2011.02.017
Slikkerveer J, Kleijn SA, Appelman Y, et al. Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: pilot of the Sonolysis study. Ultrasound Med Biol. 2012;38(2):247–52.
doi: 10.1016/j.ultrasmedbio.2011.11.001 pubmed: 22178160
Niccoli G, Scalone G, Lerman A, Crea F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024–33.
doi: 10.1093/eurheartj/ehv484 pubmed: 26364289
Aggarwal S, Xie F, High R, Pavlides G, Porter TR. Prevalence and predictive value of microvascular flow abnormalities after successful contemporary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. J Am Soc Echocardiogr. 2018;31(6):674–82.
doi: 10.1016/j.echo.2018.01.009 pubmed: 29525249
Symons R, Pontone G, Schwitter J, Francone M, Iglesias JF, Barison A, Zalewski J, de Luca L, Degrauwe S, Claus P, Guglielmo M. Long-term incremental prognostic value of cardiovascular magnetic resonance after ST-segment elevation myocardial infarction: a study of the collaborative registry on CMR in STEMI. JACC Cardiovasc Imaging. 2018;11(6):813–25.
doi: 10.1016/j.jcmg.2017.05.023 pubmed: 28823746
Qian L, Xie F, Xu D, Porter TR. Prognostic value of resting myocardial contrast echocardiography: a meta-analysis. Echo Res Pract. 2020;7(3):19–28.
doi: 10.1530/ERP-20-0023 pubmed: 32698153 pmcid: 7487191
Mathias W, Tsutsui JM, Tavares BG, Xie F, Aguiar MO, Garcia DR, Oliveira MT, Soeiro A, Nicolau JC, Lemos PA, Rochitte CE. Diagnostic ultrasound impulses improve microvascular flow in patients with STEMI receiving intravenous microbubbles. J Am Coll Cardiol. 2016;67(21):2506–15.
doi: 10.1016/j.jacc.2016.03.542 pubmed: 27230046
Wu J, Xie F, Lof J, Sayyed S, Porter TR. Utilization of modified diagnostic ultrasound and microbubbles to reduce myocardial infarct size. Heart. 2015;101(18):1468–74.
doi: 10.1136/heartjnl-2015-307625 pubmed: 26109588
Müller AM, Räpple V, Bradaric C, Koppara T, Kehl V, Fusaro M, Cassese S, Ott I, Kastrati A, Laugwitz KL, Ibrahim T. Outcomes of endovascular treatment for infrapopliteal peripheral artery disease based on the updated TASC II classification. Vasc Med. 2021;26(1):18–25.
doi: 10.1177/1358863X20967091 pubmed: 33256573
Schwarze V, Lindner F, Marschner C, Negrão de Figueiredo G, Rübenthaler J, Clevert DA. Single-center study: the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing focal splenic lesions compared to CT and MRI. Clin Hemorheol Microcirc. 2019;73(1):65–71.
doi: 10.3233/CH-199204 pubmed: 31561333
Birdi J, Heymans SV, Collado-Lara G, Van Den Abeele K, D’hooge J, Bertrand A. Single-shot attenuation coefficient estimation for ultrasound contrast agents. Front Phys. 2022;7(10):1035539.
doi: 10.3389/fphy.2022.1035539
Wu Y, Zeng F, Zhao Y, Wu S. Emerging contrast agents for multispectral optoacoustic imaging and their biomedical applications. Chem Soc Rev. 2021;50(14):7924–40.
doi: 10.1039/D1CS00358E pubmed: 34114588
Karlinsky KT, Bismuth M, Aronovich R, Ilovitsh T. Nonlinear frequency mixing ultrasound imaging of nanoscale contrast agents. IEEE Trans Biomed Eng. 2024;71(3):866–75.
doi: 10.1109/TBME.2023.3321743 pubmed: 37812544
Yu S, Cheng B, Yao T, et al. New generation ICG-based contrast agents for ultrasound-switchable fluorescence imaging. Sci Rep. 2016;6:35942.
doi: 10.1038/srep35942 pubmed: 27775014 pmcid: 5075910

Auteurs

Arif Albulushi (A)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA. dr.albulushi@gmail.com.
Advanced Heart Failure & Transplant Cardiology, University of Nebraska Medical Center, Omaha, NE, USA. dr.albulushi@gmail.com.

Feng Xie (F)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Thomas R Porter (TR)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH